{"id":"https://openalex.org/W4393989295","doi":"https://doi.org/10.1158/1538-7445.am2024-ct210","title":"Abstract CT210: Phase Ib/II study of sorafenib (SOR) and pembrolizumab (PEM) in patients (pts) with advanced hepatocellular carcinoma (HCC)","display_name":"Abstract CT210: Phase Ib/II study of sorafenib (SOR) and pembrolizumab (PEM) in patients (pts) with advanced hepatocellular carcinoma (HCC)","publication_year":2024,"publication_date":"2024-04-05","ids":{"openalex":"https://openalex.org/W4393989295","doi":"https://doi.org/10.1158/1538-7445.am2024-ct210"},"language":"en","primary_location":{"id":"doi:10.1158/1538-7445.am2024-ct210","doi":"https://doi.org/10.1158/1538-7445.am2024-ct210","is_oa":false,"landing_page_url":"http://dx.doi.org/10.1158/1538-7445.am2024-ct210","pdf_url":null,"source":{"id":"https://openalex.org/S168522863","display_name":"Cancer Research","issn_l":"0008-5472","issn":["0008-5472","1538-7445"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320273","host_organization_name":"American Association for Cancer Research","host_organization_lineage":["https://openalex.org/P4310320273"],"host_organization_lineage_names":["American Association for Cancer Research"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer Research","raw_type":"journal-article"},"volume":null,"type":"conference-abstract","is_traditional":false,"indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5055725897","display_name":"Renuka V. Iyer","orcid":"https://orcid.org/0000-0003-3643-8621","observed_orcids":["https://orcid.org/0000-0003-3643-8621"]},"institutions":[{"id":"https://openalex.org/I1292894508","display_name":"Roswell Park Comprehensive Cancer Center","ror":"https://ror.org/0499dwk57","country_code":"US","type":"facility","lineage":["https://openalex.org/I1292894508"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Renuka Iyer","raw_affiliation_strings":["1Roswell Park Comprehensive Cancer Center, Buffalo, NY;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Roswell Park Comprehensive Cancer Center, Buffalo, NY;","institution_ids":["https://openalex.org/I1292894508"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5093519757","display_name":"Sahithi Sonti","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1292894508","display_name":"Roswell Park Comprehensive Cancer Center","ror":"https://ror.org/0499dwk57","country_code":"US","type":"facility","lineage":["https://openalex.org/I1292894508"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Sahithi Sonti","raw_affiliation_strings":["1Roswell Park Comprehensive Cancer Center, Buffalo, NY;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Roswell Park Comprehensive Cancer Center, Buffalo, NY;","institution_ids":["https://openalex.org/I1292894508"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5004814161","display_name":"Devalingam Mahalingam","orcid":"https://orcid.org/0000-0002-2979-9894","observed_orcids":["https://orcid.org/0000-0002-2979-9894"]},"institutions":[{"id":"https://openalex.org/I4390039227","display_name":"Robert H. Lurie Comprehensive Cancer Center of Northwestern University","ror":"https://ror.org/02p4far57","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210147348","https://openalex.org/I4390039227"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Devalingam Mahalingam","raw_affiliation_strings":["2Robert H. Lurie Comprehensive Cancer Center of Northwestern University, Chicago, IL"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"2Robert H. Lurie Comprehensive Cancer Center of Northwestern University, Chicago, IL","institution_ids":["https://openalex.org/I4390039227"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5090466020","display_name":"Sarbajit Mukherjee","orcid":"https://orcid.org/0000-0003-2153-3896","observed_orcids":["https://orcid.org/0000-0003-2153-3896"]},"institutions":[{"id":"https://openalex.org/I1292894508","display_name":"Roswell Park Comprehensive Cancer Center","ror":"https://ror.org/0499dwk57","country_code":"US","type":"facility","lineage":["https://openalex.org/I1292894508"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Sarbajit Mukherjee","raw_affiliation_strings":["1Roswell Park Comprehensive Cancer Center, Buffalo, NY;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Roswell Park Comprehensive Cancer Center, Buffalo, NY;","institution_ids":["https://openalex.org/I1292894508"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5064024246","display_name":"Sayan Chakraborty","orcid":"https://orcid.org/0000-0002-5591-8164","observed_orcids":["https://orcid.org/0000-0002-5591-8164"]},"institutions":[{"id":"https://openalex.org/I1292894508","display_name":"Roswell Park Comprehensive Cancer Center","ror":"https://ror.org/0499dwk57","country_code":"US","type":"facility","lineage":["https://openalex.org/I1292894508"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Sayan Chakraborty","raw_affiliation_strings":["1Roswell Park Comprehensive Cancer Center, Buffalo, NY;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Roswell Park Comprehensive Cancer Center, Buffalo, NY;","institution_ids":["https://openalex.org/I1292894508"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5011054139","display_name":"Kristopher M. Attwood","orcid":"https://orcid.org/0000-0002-7229-5472","observed_orcids":["https://orcid.org/0000-0002-7229-5472","https://orcid.org/0009-0003-3874-1293"]},"institutions":[{"id":"https://openalex.org/I1292894508","display_name":"Roswell Park Comprehensive Cancer Center","ror":"https://ror.org/0499dwk57","country_code":"US","type":"facility","lineage":["https://openalex.org/I1292894508"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Kristopher Attwood","raw_affiliation_strings":["1Roswell Park Comprehensive Cancer Center, Buffalo, NY;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Roswell Park Comprehensive Cancer Center, Buffalo, NY;","institution_ids":["https://openalex.org/I1292894508"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5010801213","display_name":"Anthony M. George","orcid":"https://orcid.org/0000-0002-2709-126X","observed_orcids":["https://orcid.org/0000-0002-2709-126X"]},"institutions":[{"id":"https://openalex.org/I1292894508","display_name":"Roswell Park Comprehensive Cancer Center","ror":"https://ror.org/0499dwk57","country_code":"US","type":"facility","lineage":["https://openalex.org/I1292894508"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Anthony George","raw_affiliation_strings":["1Roswell Park Comprehensive Cancer Center, Buffalo, NY;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Roswell Park Comprehensive Cancer Center, Buffalo, NY;","institution_ids":["https://openalex.org/I1292894508"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5014024833","display_name":"Orla Maguire","orcid":"https://orcid.org/0000-0003-0544-560X","observed_orcids":["https://orcid.org/0000-0003-0544-560X"]},"institutions":[{"id":"https://openalex.org/I1292894508","display_name":"Roswell Park Comprehensive Cancer Center","ror":"https://ror.org/0499dwk57","country_code":"US","type":"facility","lineage":["https://openalex.org/I1292894508"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Orla Maguire","raw_affiliation_strings":["1Roswell Park Comprehensive Cancer Center, Buffalo, NY;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Roswell Park Comprehensive Cancer Center, Buffalo, NY;","institution_ids":["https://openalex.org/I1292894508"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5033083387","display_name":"Hans Minderman","orcid":"https://orcid.org/0000-0003-4987-9266","observed_orcids":["https://orcid.org/0000-0003-4987-9266"]},"institutions":[{"id":"https://openalex.org/I1292894508","display_name":"Roswell Park Comprehensive Cancer Center","ror":"https://ror.org/0499dwk57","country_code":"US","type":"facility","lineage":["https://openalex.org/I1292894508"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Hans Minderman","raw_affiliation_strings":["1Roswell Park Comprehensive Cancer Center, Buffalo, NY;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Roswell Park Comprehensive Cancer Center, Buffalo, NY;","institution_ids":["https://openalex.org/I1292894508"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5033837903","display_name":"Christos K Fountzilas","orcid":"https://orcid.org/0000-0003-3837-5644","observed_orcids":["https://orcid.org/0000-0003-3837-5644"]},"institutions":[{"id":"https://openalex.org/I1292894508","display_name":"Roswell Park Comprehensive Cancer Center","ror":"https://ror.org/0499dwk57","country_code":"US","type":"facility","lineage":["https://openalex.org/I1292894508"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Christos Fountzilas","raw_affiliation_strings":["1Roswell Park Comprehensive Cancer Center, Buffalo, NY;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Roswell Park Comprehensive Cancer Center, Buffalo, NY;","institution_ids":["https://openalex.org/I1292894508"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":2,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":1,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":"84","issue":"7_Supplement","first_page":"CT210","last_page":"CT210"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10073","display_name":"Hepatocellular Carcinoma Treatment and Prognosis","score":0.9961000084877014,"subfield":{"id":"https://openalex.org/subfields/2721","display_name":"Hepatology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10073","display_name":"Hepatocellular Carcinoma Treatment and Prognosis","score":0.9961000084877014,"subfield":{"id":"https://openalex.org/subfields/2721","display_name":"Hepatology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10158","display_name":"Cancer Immunotherapy and Biomarkers","score":0.0034000000450760126,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11067","display_name":"Colorectal Cancer Treatments and Studies","score":0.00019999999494757503,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/sorafenib","display_name":"sorafenib","score":0.9940000176429749},{"id":"https://openalex.org/keywords/pembrolizumab","display_name":"pembrolizumab","score":1.0},{"id":"https://openalex.org/keywords/hepatocellular-carcinoma","display_name":"hepatocellular carcinoma","score":0.9120000004768372},{"id":"https://openalex.org/keywords/immune-checkpoint-inhibitors","display_name":"immune checkpoint inhibitors","score":0.7699999809265137},{"id":"https://openalex.org/keywords/combination-therapy","display_name":"combination therapy","score":0.7509999871253967},{"id":"https://openalex.org/keywords/immune-checkpoint-blockade","display_name":"immune checkpoint blockade","score":0.4569999873638153},{"id":"https://openalex.org/keywords/tumor-infiltrating-lymphocytes","display_name":"tumor-infiltrating lymphocytes","score":0.621999979019165},{"id":"https://openalex.org/keywords/pd-l1-expression","display_name":"PD-L1 expression","score":0.6370000243186951},{"id":"https://openalex.org/keywords/pd-1-expression","display_name":"PD-1 expression","score":0.5410000085830688},{"id":"https://openalex.org/keywords/overall-response-rate","display_name":"overall response rate","score":0.5170000195503235},{"id":"https://openalex.org/keywords/progression-free-survival","display_name":"progression-free survival","score":0.8289999961853027},{"id":"https://openalex.org/keywords/safety-and-tolerability","display_name":"safety and tolerability","score":0.49799999594688416},{"id":"https://openalex.org/keywords/antitumor-immunity","display_name":"antitumor immunity","score":0.4399999976158142},{"id":"https://openalex.org/keywords/alpha-fetoprotein","display_name":"alpha-fetoprotein","score":0.5550000071525574}],"concepts":[{"id":"https://openalex.org/C2778695046","wikidata":"https://www.wikidata.org/wiki/Q421136","display_name":"Sorafenib","level":3,"score":0.8889256715774536},{"id":"https://openalex.org/C2778019345","wikidata":"https://www.wikidata.org/wiki/Q1148337","display_name":"Hepatocellular carcinoma","level":2,"score":0.8832831382751465},{"id":"https://openalex.org/C2780057760","wikidata":"https://www.wikidata.org/wiki/Q13896859","display_name":"Pembrolizumab","level":4,"score":0.7914987802505493},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.7512343525886536},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.6071826219558716},{"id":"https://openalex.org/C90924648","wikidata":"https://www.wikidata.org/wiki/Q120569","display_name":"Gastroenterology","level":1,"score":0.4760824739933014},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.44623029232025146},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.20930612087249756},{"id":"https://openalex.org/C2777701055","wikidata":"https://www.wikidata.org/wiki/Q1427096","display_name":"Immunotherapy","level":3,"score":0.06452286243438721}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1158/1538-7445.am2024-ct210","doi":"https://doi.org/10.1158/1538-7445.am2024-ct210","is_oa":false,"landing_page_url":"http://dx.doi.org/10.1158/1538-7445.am2024-ct210","pdf_url":null,"source":{"id":"https://openalex.org/S168522863","display_name":"Cancer Research","issn_l":"0008-5472","issn":["0008-5472","1538-7445"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320273","host_organization_name":"American Association for Cancer Research","host_organization_lineage":["https://openalex.org/P4310320273"],"host_organization_lineage_names":["American Association for Cancer Research"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer Research","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"score":1.0,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W3005305723","https://openalex.org/W4415756350","https://openalex.org/W2914094937","https://openalex.org/W2790105191","https://openalex.org/W2891123876","https://openalex.org/W4406869106","https://openalex.org/W3150434687","https://openalex.org/W2792539022","https://openalex.org/W2243707214","https://openalex.org/W2248852318"],"abstract_inverted_index":{"Abstract":[0],"Background:":[1],"SOR":[2,20,46,79,94,113,171,432],"is":[3,410],"an":[4,41,148,163],"active":[5,414],"agent":[6],"and":[7,26,47,115,182,247,261,272,329,341,398,413,433,447,482,511],"has":[8],"favorable":[9,428],"immunomodulatory":[10,429],"effects":[11,430],"in":[12,40,49,239,288,316,356,391,485],"HCC.":[13,35,53,420,444],"Combinations":[14],"of":[15,45,66,208,283,394,423,431,437,479,496],"immune":[16],"checkpoint":[17],"inhibitors":[18],"with":[19,34,51,56,78,166,170,218,295,365,383,402,418,442,488],"may":[21],"enhance":[22],"effector":[23],"T-cell":[24],"function":[25],"lead":[27],"to":[28,161,305,352,360,378],"improved":[29,384],"clinical":[30],"outcomes":[31],"for":[32,81,184,416,440,500],"patients":[33,50,241,244,284,441,486],"We":[36],"tested":[37],"this":[38,438],"hypothesis":[39],"open-label,":[42],"multicenter":[43],"study":[44,146,157,425,478],"PEM":[48,96,361,379],"advanced":[52,57,419,443,489],"Methods:":[54],"Pts":[55,75],"or":[58,123,221],"metastatic":[59],"HCC,":[60],"CP":[61],"Class":[62],"A,":[63],"ECOG":[64],"PS":[65],"0/1":[67],"were":[68,76,178,197,216,265,321],"included.":[69],"One":[70,252,291],"prior":[71,359],"therapy":[72],"was":[73,128,140,203,226,237,363,381,400],"allowed.":[74],"treated":[77],"alone":[80,172],"4":[82],"weeks":[83,131],"(lead-in)":[84],"at":[85,180,375],"a":[86,255,286,302,372,411],"stable":[87],"dose":[88],"(minimum":[89],"200":[90],"BID),":[91],"followed":[92],"by":[93,335,344],"plus":[95],"200mg":[97],"IV":[98],"q3":[99],"weeks.":[100],"The":[101,137,145,224,307,354,421],"phase":[102],"Ib":[103],"part":[104],"included":[105],"the":[106,112,133,156,191,209,317,392,427,497],"first":[107],"6":[108,248],"pts":[109,194,210,215,417],"who":[110],"completed":[111],"lead-in":[114],"began":[116],"SOR+PEM.":[117,306],"Treatment":[118],"continued":[119],"until":[120],"disease":[121,297],"progression":[122],"unacceptable":[124],"toxicity.":[125],"Disease":[126],"assessment":[127],"performed":[129],"q6":[130],"using":[132],"RECIST":[134],"1.1":[135],"criteria.":[136],"primary":[138],"endpoint":[139],"overall":[141,262],"response":[142,236,300,304],"rate":[143],"(ORR).":[144],"used":[147],"exact":[149],"one-stage":[150],"design.":[151],"With":[152],"27":[153,196],"evaluable":[154,198],"pts,":[155],"had":[158,211,250,254,285,301],"80%":[159],"power":[160],"detect":[162],"ORR":[164,225],"\u226520%":[165],"SOR/PEM":[167],"vs.":[168],"5%":[169],"(a=0.05).":[173],"Peripheral":[174],"blood":[175,448],"mononuclear":[176],"cells":[177],"collected":[179],"baseline":[181,351,397],"on-treatment":[183],"correlative":[185,449],"analyses":[186,450],"(flow":[187],"cytometry).":[188],"Results:":[189],"Of":[190],"37":[192],"total":[193],"enrolled,":[195],"(9":[199],"female).":[200],"Median":[201,258],"age":[202],"68":[204],"years.":[205],"Forty-four":[206],"percent":[207,282],"viral":[212],"hepatitis.":[213],"Four":[214],"pre-treated":[217],"atezolizumab/bevacizumab":[219,292],"(n=3)":[220],"tivozanib/durvalumab":[222],"(n=1).":[223],"33%":[227],"(95%":[228,267,274],"CI:":[229,268,275],"18":[230],"-":[231,270,277,338,347],"52%)":[232],"p=":[233],"0.08.":[234],"Best":[235],"PR":[238],"9":[240],"(33%),":[242],"12":[243],"SD":[245],"(44%),":[246],"(22%)":[249],"PD.":[251],"patient":[253],"near":[256],"CR.":[257],"progression-free":[259],"(PFS)":[260],"survival":[263],"(OS)":[264],"4.8":[266],"3.4":[269],"16.3)":[271],"28.5":[273],"15.2":[276],"57.7)":[278],"months":[279],"respectively.":[280],"Fifty-two":[281],"decrease":[287],"AFP":[289],">50%.":[290],"pretreated":[293],"pt":[294],"progressive":[296],"as":[298],"best":[299],"near-complete":[303],"most":[308],"common":[309],"grade":[310],"\u22653":[311],"treatment-related":[312],"adverse":[313],"events":[314],"(AEs)":[315],"safety":[318],"population":[319],"(n=37)":[320],"hypertension":[322],"(16%),":[323],"immune-related":[324],"AEs":[325],"(11%),":[326],"fatigue":[327],"(8%)":[328],"diarrhea":[330],"(8%).":[331],"CD8+":[332],"T-cells":[333],"increased":[334],"5.5%":[336],"(-35.6":[337],"36.9%;":[339],"p=0.035)":[340],"Tregs":[342,358,395],"decreased":[343],"14.73%":[345],"(-378.6":[346],"61%,":[348],"p=0.049)":[349],"from":[350],"C1D1.":[353],"increase":[355,390],"activated":[357],"initiation":[362],"associated":[364,382,401],"worse":[366,403],"OS":[367],"(HR:":[368,386,405],"1.8,":[369],"p=0.03)":[370],"while":[371],"higher":[373],"Teff/Treg":[374],"C1D1":[376],"(prior":[377],"initiation)":[380],"PFS":[385,404],"0.4,":[387],"p=0.036).":[388],"An":[389],"percentage":[393],"between":[396],"C4D1":[399],"2;":[406],"p=0.03).":[407],"Conclusions:":[408],"SOR+PEM":[409],"safe":[412],"treatment":[415],"results":[422],"our":[424],"confirm":[426],"support":[434],"further":[435],"exploration":[436],"regimen":[439],"Further":[445],"tissue":[446],"are":[451],"ongoing.":[452],"NCT03211416.":[453],"Citation":[454],"Format:":[455],"Renuka":[456],"Iyer,":[457],"Sahithi":[458],"Sonti,":[459],"Devalingam":[460],"Mahalingam,":[461],"Sarbajit":[462],"Mukherjee,":[463],"Sayan":[464],"Chakraborty,":[465],"Kristopher":[466],"Attwood,":[467],"Anthony":[468],"George,":[469],"Orla":[470],"Maguire,":[471],"Hans":[472],"Minderman,":[473],"Christos":[474],"Fountzilas.":[475],"Phase":[476],"Ib/II":[477],"sorafenib":[480],"(SOR)":[481],"pembrolizumab":[483],"(PEM)":[484],"(pts)":[487],"hepatocellular":[490],"carcinoma":[491],"(HCC)":[492],"[abstract].":[493],"In:":[494],"Proceedings":[495],"American":[498],"Association":[499],"Cancer":[501,523],"Research":[502],"Annual":[503],"Meeting":[504],"2024;":[505],"Part":[506],"2":[507],"(Late-Breaking,":[508],"Clinical":[509],"Trial,":[510],"Invited":[512],"Abstracts);":[513],"2024":[514],"Apr":[515],"5-10;":[516],"San":[517],"Diego,":[518],"CA.":[519],"Philadelphia":[520],"(PA):":[521],"AACR;":[522],"Res":[524],"2024;84(7_Suppl):Abstract":[525],"nr":[526],"CT210.":[527]},"counts_by_year":[{"year":2026,"cited_by_count":1}],"updated_date":"2026-10-27T15:51:10.671819","created_date":"2024-04-06T00:00:00"}